Oxidative stress and diabetic retinopathy
- PMID: 17641741
- PMCID: PMC1880867
- DOI: 10.1155/2007/43603
Oxidative stress and diabetic retinopathy
Abstract
Oxygen metabolism is essential for sustaining aerobic life, and normal cellular homeostasis works on a fine balance between the formation and elimination of reactive oxygen species (ROS). Oxidative stress, a cytopathic consequence of excessive production of ROS and the suppression of ROS removal by antioxidant defense system, is implicated in the development of many diseases, including Alzheimer's disease, and diabetes and its complications. Retinopathy, a debilitating microvascular complication of diabetes, is the leading cause of acquired blindness in developed countries. Many diabetes-induced metabolic abnormalities are implicated in its development, and appear to be influenced by elevated oxidative stress; however the exact mechanism of its development remains elusive. Increased superoxide concentration is considered as a causal link between elevated glucose and the other metabolic abnormalities important in the pathogenesis of diabetic complications. Animal studies have shown that antioxidants have beneficial effects on the development of retinopathy, but the results from very limited clinical trials are somewhat ambiguous. Although antioxidants are being used for other chronic diseases, controlled clinical trials are warranted to investigate potential beneficial effects of antioxidants in the development of retinopathy in diabetic patients.
Figures


References
-
- Sharma S, Oliver-Fernandez A, Liu W, Buchholz P, Walt J. The impact of diabetic retinopathy on health-related quality of life. Current Opinion in Ophthalmology. 2005;16(3):155–159. - PubMed
-
- Frank RN. Diabetic retinopathy. New England Journal of Medicine. 2004;350(1):48–58. - PubMed
-
- Aylward GW. Progressive changes in diabetics and their management. Eye. 2005;19(10):1115–1118. - PubMed
-
- Robison WG, Jr, Kador PF, Kinoshita JH. Early retinal microangiopathy: prevention with aldose reductase inhibitors. Diabetic Medicine. 1985;2(3):196–199. - PubMed
-
- Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. International Journal of Biochemistry and Cell Biology. 2004;36(7):1206–1237. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical